Moderna, Inc. Share Price & Technical Analysis
MRNA · $46.88 (-0.80%)
Healthcare / Biotechnology
$46.88
-0.80%
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses inclu…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
1% return in May, 7% avg return in past 3 year May month.
58% return in 2026, -37% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 48% | 23% | -3% | -11% | 1% | – | – | – | – | – | – | – | 58% |
| 25 | -7% | -19% | -9% | -1% | -4% | 3% | 8% | -13% | 8% | 4% | -2% | 18% | -13% |
| 24 | 1% | -9% | 15% | 4% | 28% | -15% | 2% | -22% | -14% | -19% | -21% | -4% | -53% |
| 23 | -3% | -21% | 11% | -13% | -3% | -5% | -3% | -3% | -10% | -26% | 3% | 30% | -44% |
| 22 | -31% | -12% | 13% | -22% | 8% | -2% | 16% | -19% | -10% | 26% | 14% | 4% | -18% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$21.39B
P/E ratio
—
52W high
$59.55
52W low
$22.28
Volume
42,23,676
Beta
1.06
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Moderna, Inc. share price today?
- Moderna, Inc. (MRNA) last traded around $46.88 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MRNA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MRNA. Download the app for real-time alerts.
- How can I analyze Moderna, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.